RBS has right medicine for The GADA Group

Share this article: Twitter Facebook Print Share this page with a friend/colleague

July 2011

Livingstone Partners’ Healthcare team has advised the shareholders of The GADA Group on a significant growth equity investment in the group by private equity investor RBS Equity Finance.

GADA is a leading medical devices and technology distributor and service provider, headquartered in the UK, with operations in Italy, Turkey and Romania. The group provides highly specialised, scalable, technically-led distribution and maintenance services to leading public and private sector hospitals as well as leading OEMs.

RBS’ investment will support GADA in the acquisition of complementary businesses with a focus on Central and Eastern Europe, whilst also enabling GADA to further develop its broad range of products and services with which to support its hospital customers.

Sante Giovanni Albonetti, Chief Executive of GADA said: “We received first class advice from Livingstone throughout the fund raising process. Livingstone added real value to us and we are delighted that they found us the ideal partner, in RBS Equity Finance, to support our growth plans.”

Richard Fetterman, Partner at Livingstone and Head of Healthcare in London commented: “This transaction demonstrates our ability to create and manage complex cross-border projects and to deliver to our clients ideal funding structures to support future growth.”

Kristian Gavan, Director at Livingstone added: “We are delighted to have identified RBS Equity Finance as the funding partner for GADA going forward. This deal is a further example both of our fund raising capabilities and our healthcare credentials.”

The GADA transaction is the fourth Healthcare sector deal completed by Livingstone in 2011 to date.

For further information contact:
Richard Fetterman, Partner
Tel: 020 7484 4739
Email: fetterman@livingstonepartners.co.uk

Kristian Gavan, Director
Tel: 020 7484 4747
Email: gavan@livingstonepartners.co.uk